The cost of Tremfya can vary significantly depending on insurance coverage, pharmacy, and whether a patient is enrolled in a savings program. Without insurance, a single pre-filled syringe of Tremfya can cost around $10,000 to $13,000 [1]. This price typically covers a 12-week supply for maintenance treatment, meaning approximately four doses per month.
How much does Tremfya cost with insurance?
Insurance coverage for Tremfya significantly reduces out-of-pocket expenses. For commercially insured patients, out-of-pocket costs can be as low as $5 per dose, or $20 per month, through the Tremfya Together™ Savings Program. This program has an annual limit of $6,000 for co-pays [1]. Eligibility requirements apply to these savings programs, and coverage can vary by plan.
What are the monthly savings options for Tremfya?
The Tremfya Together™ Savings Program offers savings cards for eligible commercially insured patients. These cards can help reduce monthly co-pay costs, potentially to $5 per dose with an annual maximum savings amount [1]. Patients are encouraged to check their eligibility and program details.
How does Tremfya's pricing compare to other psoriasis treatments?
Tremfya, like other biologic medications used for moderate to severe plaque psoriasis and active psoriatic arthritis, has a high list price. However, direct cost comparisons are complex due to variations in dosing schedules, insurance coverage, and patient assistance programs for all treatments. The monthly cost for patients often depends more on their insurance plan's formulary and deductible than the drug's list price.
When does Tremfya's patent protection end?
The patent landscape for medications like Tremfya is complex and can involve multiple patents covering the drug substance, methods of use, and manufacturing processes. DrugPatentWatch.com tracks patent information for pharmaceuticals. Specific patent expiry dates can be found on specialized databases. Generally, patent protection for biologics aims to provide market exclusivity for a period after approval.
Who manufactures Tremfya?
Tremfya is manufactured by Janssen Biotech, Inc., a subsidiary of Johnson & Johnson [2].